Beyond fibrinolysis: the role of plasminogen activator inhibitor-1 and vitronectin in vascular wound healing. (Q47772414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Beyond fibrinolysis: the role of plasminogen activator inhibitor-1 and vitronectin in vascular wound healing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Steingrimur Stefansson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

C C Haudenschild

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

Trends in Cardiovascular Medicine

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

175-180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

Plasminogen activator inhibitor (PAI-1) in plasma and platelets

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Impaired arterial neointima formation in mice with disruption of the plasminogen gene

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Ligand binding regulates the directed movement of beta1 integrins on fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Molecular therapies for vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Thrombosis and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

α v β 3 Integrin Expression in Normal and Atherosclerotic Artery

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Integrins: versatility, modulation, and signaling in cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

The urokinase receptor is a major vitronectin-binding protein on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Expression of integrins and basement membrane components by wound keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Making connections count

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Cell migration: a physically integrated molecular process

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

The serpin-proteinase complex revealed

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Serpin-protease complexes are trapped as stable acyl-enzyme intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Binding sites on native and multimeric vitronectin exhibit similar affinity for heparin the influence of self-association and multivalence on ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

The cell adhesion domain in plasma vitronectin is cryptic.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Serpin tertiary structure transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Localization of vitronectin in the normal and atherosclerotic human vessel wall

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Regulation of integrin function by the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

Native and multimeric vitronectin exhibit similar affinity for heparin. Differences in heparin binding properties induced upon denaturation are due to self-association into a multivalent form

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2898%2900003-6

7 January 2021

10.1016/S1050-1738(98)00003-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21235930%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference